Advanced search
Publication Cover
Pain Management Volume 1, 2011 - Issue 6
Submit an article Journal homepage
25
Views
0
CrossRef citations to date
0
Altmetric
Review

Learning New Tricks from an Old Dog: Using Experimental Autoimmune Encephalomyelitis to Study Comorbid Symptoms in Multiple Sclerosis

Travis Musgrave1 Centre for Neuroscience, University of Alberta, Edmonton, AB, CanadaView further author information
,
Camille J Olechowski1 Centre for Neuroscience, University of Alberta, Edmonton, AB, CanadaView further author information
&
Bradley J KerrCorrespondence[email protected]
View further author information
Pages 571-576 | Published online: 02 Nov 2011

Bibliography

  • Nikic I , MerklerD, SorbaraC et al. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat. Med. 17(4) , 495–499 (2011).
  • Ouardouz M , CoderreE, BasakA et al. Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors. Ann. Neurol. 65(2) , 151–159 (2009).
  • Ouardouz M , CoderreE, ZamponiGW et al. Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors. Ann. Neurol. 65(2) , 160–166 (2009).
  • Trapp BD , PetersonJ, RansohoffRM, RudickR, MorkS, BoL. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med.338(5) , 278–285 (1998).
  • Osterberg A , BoivieJ, ThuomasKA. Central pain in multiple sclerosis–prevalence and clinical characteristics. Eur. J. Pain9(5) , 531–542 (2005).
  • Svendsen KB , JensenTS, HansenHJ, BachFW. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain114(3) , 473–481 (2005).
  • O‘Connor AB , SchwidSR, HerrmannDN, MarkmanJD, DworkinRH. Pain associated with multiple sclerosis: systematic review and proposed classification. Pain137(1) , 96–111 (2008).
  • Indaco A , IachettaC, NappiC, SocciL, CarrieriPB. Chronic and acute pain syndromes in patients with multiple sclerosis. Acta Neurol. (Napoli)16(3) , 97–102 (1994).
  • Svendsen KB , JensenTS, OvervadK, HansenHJ, Koch-HenriksenN, BachFW. Pain in patients with multiple sclerosis: a population-based study. Arch. Neurol.60(8) , 1089–1094 (2003).
  • Denic A , JohnsonAJ, BieberAJ, WarringtonAE, RodriguezM, PirkoI. The relevance of animal models in multiple sclerosis research. Pathophysiology18(1) , 21–29 (2011).
  • Owens T , SriramS. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol. Clin.13(1) , 51–73 (1995).
  • Bradl M , HohlfeldR. Molecular pathogenesis of neuroinflammation. J. Neurol. Neurosurg. Psychiatry74(10) , 1364–1370 (2003).
  • Baxter AG . The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol.7(11) , 904–912 (2007).
  • Steinman L , ZamvilSS. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol.60(1) , 12–21 (2006).
  • Berard JL , WolakK, FournierS, DavidS. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice. Glia58(4) , 434–445 (2010).
  • Aicher SA , SilvermanMB, WinklerCW, BeboBF Jr. Hyperalgesia in an animal model of multiple sclerosis. Pain110(3) , 560–570 (2004).
  • Lynch JL , GallusNJ, EricsonME, BeitzAJ. Analysis of nociception, sex and peripheral nerve innervation in the TMEV animal model of multiple sclerosis. Pain136(3) , 293–304 (2008).
  • Olechowski CJ , TruongJJ, KerrBJ. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain141(1–2) , 156–164 (2009).
  • Rodrigues DH , SachsD, TeixeiraAL. Mechanical hypernociception in experimental autoimmune encephalomyelitis. Arq. Neuropsiquiatr.67(1) , 78–81 (2009).
  • Olechowski CJ , ParmarA, MillerB et al. A diminished response to formalin stimulation reveals a role for the glutamate transporters in the altered pain sensitivity of mice with experimental autoimmune encephalomyelitis (EAE). Pain 149(3) , 565–572 (2010).
  • Vercellino M , MerolaA, PiacentinoC et al. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J. Neuropathol. Exp. Neurol. 66(8) , 732–739 (2007).
  • Werner P , PittD, RaineCS. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann. Neurol.50(2) , 169–180 (2001).
  • Binns BC , HuangY, GoettlVM, HackshawKV, StephensRL Jr. Glutamate uptake is attenuated in spinal deep dorsal and ventral horn in the rat spinal nerve ligation model. Brain Res.1041(1) , 38–47 (2005).
  • Sung B , LimG, MaoJ. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J. Neurosci.23(7) , 2899–2910 (2003).
  • Tao YX , GuJ, StephensRL Jr. Role of spinal cord glutamate transporter during normal sensory transmission and pathological pain states. Mol. Pain1 , 30 (2005).
  • Rothstein JD , PatelS, ReganMR et al. β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433(7021) , 73–77 (2005).
  • Ramos KM , LewisMT, MorganKN et al. Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders. Neuroscience 169(4) , 1888–1900 (2010).
  • Thibault K , CalvinoB, PezetS. Characterisation of sensory abnormalities observed in an animal model of multiple sclerosis: a behavioural and pharmacological study. Eur. J. Pain15(3) , 231.E1–E16 (2011).
  • Sloane E , LedeboerA, SeibertW et al. Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. Brain Behav. Immun. 23(1) , 92–100 (2009).
  • Melanson M , MiaoP, EisenstatD et al. Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-α in the dorsal root ganglia. Mult. Scler. 15(10) , 1135–1145 (2009).
  • Schafers M , LeeDH, BrorsD, YakshTL, SorkinLS. Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-α after spinal nerve ligation. J. Neurosci.23(7) , 3028–3038 (2003).
  • Schafers M , SvenssonCI, SommerC, SorkinLS. Tumor necrosis factor-α induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J. Neurosci.23(7) , 2517–2521 (2003).
  • Pollak Y , OrionE, GoshenI, OvadiaH, YirmiyaR. Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of ‘depression due to multiple sclerosis‘. Brain Behav. Immun.16(5) , 533–543 (2002).
  • Pollak Y , OvadiaH, GoshenI et al. Behavioral aspects of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 104(1) , 31–36 (2000).
  • Dantzer R . Cytokine-induced sickness behavior: mechanisms and implications. Ann. NY Acad. Sci.933 , 222–234 (2001).
  • Dantzer R , O‘ConnorJC, FreundGG, JohnsonRW, KelleyKW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci.9(1) , 46–56 (2008).
  • Maes M . Evidence for an immune response in major depression: a review and hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiatry19(1) , 11–38 (1995).
  • Musgrave T , BensonC, WongG et al. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE). Brain Behav. Immun. 25(8) , 1677–1688 (2011).
  • Pollak Y , OvadiaH, OrionE, WeidenfeldJ, YirmiyaR. The EAE-associated behavioral syndrome: I. Temporal correlation with inflammatory mediators. J. Neuroimmunol.137(1–2) , 94–99 (2003).
  • Sakic B , SzechtmanH, DenburgJA. Neurobehavioral alterations in autoimmune mice. Neurosci. Biobehav. Rev.21(3) , 327–340 (1997).
  • Sakic B , SzechtmanH, TalangbayanH, DenburgSD, CarbotteRM, DenburgJA. Disturbed emotionality in autoimmune MRL-lpr mice. Physiol. Behav.56(3) , 609–617 (1994).
  • Szechtman H , SakicB, DenburgJA. Behaviour of MRL mice: an animal model of disturbed behaviour in systemic autoimmune disease. Lupus6(3) , 223–229 (1997).
  • Pollak Y , OvadiaH, OrionE, YirmiyaR. The EAE-associated behavioral syndrome: II. Modulation by anti-inflammatory treatments. J. Neuroimmunol.137(1–2) , 100–108 (2003).
  • Baker GB , SowaB, ToddKG. Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders? J. Psychiatry Neurosci.32(5) , 313–315 (2007).
  • McManus DJ , BakerGB, MartinIL, GreenshawAJ, MckennaKF. Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain. Biochem. Pharmacol.43(11) , 2486–2489 (1992).
  • Todd KG , BakerGB. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline. J. Affect. Disord.35(3) , 125–129 (1995).
  • Bourin M , HascoetM, ColombelMC, CouttsRT, BakerGB. Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice. J. Psychiatry Neurosci.27(3) , 178–185 (2002).
  • Maki Y , InoueT, IzumiT et al. Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats. Eur. J. Pharmacol. 406(3) , 411–418 (2000).
  • Griebel G , CuretO, PerraultG, SangerDJ. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels. Neuropharmacology37(7) , 927–935 (1998).
  • Paslawski T , TreitD, BakerGB, GeorgeM, CouttsRT. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Psychopharmacology (Berl.)127(1) , 19–24 (1996).
  • Zhao Z , ZhangHT, BootzinE, MillanMJ, O‘DonnellJM. Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs. Neuropsychopharmacology34(6) , 1467–1481 (2009).
  • Bhat R , AxtellR, MitraA et al. Inhibitory role for GABA in autoimmune inflammation. Proc. Natl Acad. Sci. USA 107(6) , 2580–2585 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.